$5.40
-0.16-2.88%
Comments
Loading...
Latest Y-mAbs Therapeutics Stock News | NASDAQ:YMAB | Benzinga
Get the latest news on Y-mAbs Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Y-mAbs Therapeutics performance
Categories: All
Monday, March 03, 2025
Friday, January 31, 2025
Monday, January 13, 2025
Friday, January 10, 2025
Tuesday, January 07, 2025
Wednesday, December 11, 2024
Saturday, December 07, 2024
Thursday, December 05, 2024
Friday, November 22, 2024
Monday, November 18, 2024
Friday, November 15, 2024
Friday, November 08, 2024
Thursday, November 07, 2024
Monday, November 04, 2024
Wednesday, October 30, 2024
Tuesday, September 10, 2024
Monday, September 09, 2024
Friday, September 06, 2024
Friday, August 16, 2024
Wednesday, August 14, 2024
Tuesday, August 13, 2024
Monday, August 12, 2024
- Y-mAbs Therapeutics, Inc. Reports Q2 Loss, Misses Revenue Estimates
- Y-mAbs Therapeutics shares are trading lower ...
- Y-mAbs' Cash And Cash Equivalents Of $77.8M H...
- Y-mAbs' Anticipated 2024 Total Net Revenues N...
- Y-mAbs Therapeutics Q2 2024 GAAP EPS $(0.21) ...
- Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket